tiprankstipranks
Trending News
More News >
Crescent Biopharma (CBIO)
NASDAQ:CBIO
US Market

Crescent Biopharma (CBIO) Balance Sheet

Compare
1,022 Followers

Crescent Biopharma Balance Sheet

Crescent Biopharma's total assets for Q4 2025 were $240.29M, an increase of 73.79% from the previous quarter. CBIO total liabilities were $37.28M for the fiscal quarter, a 72.37% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 240.29M$ 35.62M$ 45.32M$ 51.81M$ 94.35M
Total Liabilities
$ 37.28M$ 51.10M$ 6.90M$ 8.88M$ 12.74M
Total Equity Gross Minority
$ 203.01M$ 5.31M$ 38.41M$ 42.93M$ 81.60M
Other Metrics
Currency in USD

Crescent Biopharma Debt to Assets